Related Experiment Video
Updated: Jul 3, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
When good Cdk5 turns bad
1Department of Physiology, University of Oklahoma Health Sciences Center, College of Medicine, Oklahoma City, OK 73104, USA. qing-guo@ouhsc.edu
Abstract:
The cyclin-dependent kinase-5 (Cdk5) is critical to normal mammalian development and has been implicated in synaptic plasticity, learning, and memory in the adult brain. But Cdk-5 activity has also been linked to neurodegenerative diseases. Could a single protein have opposing effects? A new study shows that production of a neuronal protein capable of regulating Cdk-5 activity can turn Cdk-5 from "good" to "bad." The findings may have implications for the development and treatment of conditions like Alzheimer's disease.
Insights
Cyclin-dependent kinase-5 (Cdk5) plays dual roles in brain function. A newly identified neuronal protein can shift Cdk5 activity from beneficial to detrimental, impacting neurodegenerative diseases like Alzheimer's.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Cyclin-dependent kinase-5 (Cdk5) is essential for mammalian development.
- Cdk5 is involved in synaptic plasticity, learning, and memory.
- Aberrant Cdk5 activity is linked to neurodegenerative diseases.
Purpose of the Study:
- To investigate how a single protein can modulate Cdk5 activity.
- To understand the dual role of Cdk5 in neuronal function and disease.
Main Methods:
- The study likely involved molecular biology techniques to identify and characterize the regulatory protein.
- Experiments may have assessed the impact of this protein on Cdk5 activity in neuronal models.
Main Results:
- A specific neuronal protein was found to regulate Cdk5 activity.
- This regulation can switch Cdk5 from a "good" (developmental/functional) to a "bad" (pathological) state.
Conclusions:
- The findings reveal a mechanism for Cdk5's opposing roles in the brain.
- This discovery may offer new therapeutic targets for Alzheimer's disease and other neurodegenerative conditions.
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle
DNA Damage Can Stall the Cell Cycle

